|
KIF2C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.990600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.083600E-01 |
| Normal-vs-Stage2 |
8.749500E-02 |
| Normal-vs-Stage3 |
2.241400E-01 |
| Normal-vs-Stage4 |
1.295590E-01 |
| Stage1-vs-Stage2 |
2.030200E-01 |
| Stage1-vs-Stage3 |
6.304400E-01 |
| Stage1-vs-Stage4 |
3.401600E-01 |
| Stage2-vs-Stage3 |
3.747400E-01 |
| Stage2-vs-Stage4 |
7.610000E-01 |
| Stage3-vs-Stage4 |
5.686800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.834600E-01 |
| Normal-vs-AfricanAmerican |
2.955700E-02 |
| Normal-vs-Asian |
6.458000E-01 |
| Caucasian-vs-AfricanAmerican |
3.554200E-02 |
| Caucasian-vs-Asian |
4.662000E-01 |
| AfricanAmerican-vs-Asian |
3.396200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.748200E-01 |
| Normal-vs-Female |
1.859640E-01 |
| Male-vs-Female |
6.921400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.921800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.125600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.999780E-01 |
| Normal-vs-Age(81-100Yrs) |
5.094400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.880800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.918600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.167000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.552190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.023800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.565000E-01 |
| Classical-VS-Follicular |
3.866400E-02 |
| Classical-VS-Other |
1.864800E-01 |
| Classical-VS-Normal |
3.338400E-01 |
| Tall-VS-Follicular |
2.341000E-01 |
| Tall-VS-Other |
1.980170E-01 |
| Tall-VS-Normal |
4.564000E-01 |
| Follicular-VS-Other |
5.804400E-01 |
| Follicular-VS-Normal |
5.838300E-02 |
| Other-VS-Normal |
3.898400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.662030E-01 |
| Normal-vs-N1 |
2.229000E-01 |
| N0-vs-N1 |
9.651200E-01 |
|
|
